Inhibition of AMPK-HMGCR signaling promotes the development of atherosclerosis and hepatic steatosis. Issue 3 (May 2019) - Loh, Kim; Tam, Shanna; Steinberg, Gregory; Fullerton, Morgan; Galic, Sandra; Kemp, Bruce